Insulin cost remains ‘catastrophic’ for millions of Americans, despite Inflation Reduction Act capping Medicare copay at $35

14% of Americans who rely on insulin face 'catastrophic' spending on it, meaning at least 40% of their income after food and housing goes toward insulin.